Questions swirl as vacancies on NIH advisory boards go unfilled
Since President Trump took office last January, only one new member has been added to the NIH advisory boards, key groups that make final recommendations on what research to fund at universities and medical centers, dwindling their ranks as the terms of current members expired and a handful resigned. The majority of 25 boards are now operating with less than half their full staff, according to STAT’s analysis of annual board activity reports submitted in late December to a federal database.
Vacancies have left many panels without the range of expertise needed to make informed funding decisions. Some appear to be at risk of violating federal laws governing the composition and operation of boards.
It is not clear why the Trump administration has not taken steps to fill the growing vacancies. The loss of several longtime staff members of the NIH committee’s management office, including its director, Claire Harris, who retired last year, is likely contributing to the problem. But current and former NIH officials fear the pause is part of a broader upheaval and growing politicization of NIH decision-making.
This article is reserved for STAT+ subscribers
Unlock this article – plus daily insights from Capitol Hill and the life sciences industry – by subscribing to STAT+.
Already have an account? Log in
See all packages
Berita Terkini
Berita Terbaru
Daftar Terbaru
News
Berita Terbaru
Flash News
RuangJP
Pemilu
Berita Terkini
Prediksi Bola
Technology
Otomotif
Berita Terbaru
Teknologi
Berita terkini
Berita Pemilu
Berita Teknologi
Hiburan
master Slote
Berita Terkini
Pendidikan
Resep
Jasa Backlink
Togel Deposit Pulsa
Daftar Judi Slot Online Terpercaya
Slot yang lagi gacor